Trial result ·
Effectiveness of an Extension for Community Health Outcomes case-based virtual community of practice model on clinician outcomes for the management of long COVID and fatiguing illnesses: a randomized control trial.
Written based on 1 research study on PubMed, searched on 8 Nov 2026.
What was studied
This was a cluster randomised trial. It tested ECHO. This is a virtual learning model. It is for clinicians. It uses case-based virtual community of practice sessions. The topic was Long COVID care. It also covered other infection-associated chronic conditions. These patients often face barriers to specialist care. The ECHO group was invited to weekly, expert-led sessions on Zoom. Both groups were invited to monthly webinars. Both were invited to quarterly short courses. The trial was single-blind. Data came from clinician surveys, participation records and health records.
What they found
After baseline adjustment, knowledge was higher with ECHO. The beta was 0.77. This was significant. Confidence was higher too. The beta was 0.48. This was significant. Practice changes were not significant, at 0.52. Sessions attended predicted all outcomes significantly. Specialist referrals per patient fell. The beta was -0.44. Visit length and patient load did not differ.
What it means for patients
The authors say ECHO can improve clinician knowledge. They say it can improve confidence too. This is for care of these patients. They say it also lowered specialist referrals. They call it a hopeful way to build primary care capacity.
Why it is not certain yet
Practice changes were not significant. The trial was single-blind. Data came from clinician surveys and records. A single trial can only show so much.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
Effectiveness of an Extension for Community Health Outcomes case-based virtual community of practice model on clinician outcomes for the management of long COVID and fatiguing illnesses: a randomized control trial.
PubMed · PMID 42985061We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Long COVID and ME/CFS news